You Searched For "how long will it take to make coronavirus vaccine" and got 19 results
Sort By:
Coronavirus vaccine will take at least a year to make but that's not a reason to worry — as long as you stay away from 'WhatsApp university'
Many are hoping — and waiting — for a vaccine for Covid-19. However, experts believe that it will t…
Here's why Indians are searching on Google for how to make coronavirus vaccines at home
The COVID-19 pandemic is ravaging several parts of India after the nationwide lockdown was partiall…
How long it'll take to vaccinate 20 million Americans
These are Business Insider's biggest healthcare stories for December 21.
Lydia Ramsey Pflanzer
A growing chorus of experts are deeply skeptical we'll have a coronavirus vaccine within 18 months. Here's why a shot may take years, if we can succeed in making one at all.
Understanding how the body's immune system responds to the virus is important in crafting a vaccine…
Zachary Tracer
A timeline of when Pfizer's new coronavirus vaccine could reach ordinary people — a process likely to take months
Pfizer said its coronavirus vaccine had succeeded in the final stage of clinical trials, and is mor…
Sinéad Baker,Andrew Dunn
The first trial of a potential coronavirus vaccine just started in Washington state. It will take at least a year to know if the vaccine works.
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…
Andrew Dunn
It'll take weeks to vet a COVID-19 vaccine
These are Business Insider's biggest healthcare stories for November 17.
Lydia Ramsey Pflanzer
Pfizer's and Moderna's vaccines likely work for all existing coronavirus strains. Don't worry about mutations for now, scientists say.
The coronavirus mutates slowly, which means a vaccine should be effective against all existing vers…
Aylin Woodward
One chart shows how effective Moderna's vaccine is at preventing people from getting COVID-19
Moderna's vaccine appears to perform near just as well as Pfizer's at preventing COVID-19 infection…
Hilary Brueck
Bill Gates thinks there are 8 to 10 promising coronavirus vaccine candidates and one could be ready in as little as 9 months
Gates touted the possibility of new RNA and DNA vaccines which could "turn your body into its own v…
Isobel Asher Hamilton
6 vaccine experts told us how they'll decide whether to get a coronavirus shot
Crucial vaccine results are expected by the end of this year, possibly later this month. Here's how…
Andrew Dunn
UK approves its first vaccine
These are Business Insider's biggest healthcare stories for December 2.
Lydia Ramsey Pflanzer
The FDA urges healthcare providers not to mix and match vaccines, halve doses, or extend time between shots
After some leaders have suggested short-cuts to vaccinate more people quicker, the FDA has issued g…
Anna Medaris Miller
A top Wall Street analyst sees less than a 20% chance of having a widely available coronavirus vaccine in 2021 - he told us why he's 'deeply skeptical' of Anthony Fauci's 18-month timeline
It's also unclear if having these antibodies even protects people. China and Japan have both report…
Andrew Dunn
The man in charge of evaluating coronavirus vaccines for the FDA lays out why it will take weeks to vet a COVID-19 shot
Even with Moderna and Pfizer announcing success with coronavirus vaccines, the FDA review process w…
Andrew Dunn
Dispensed: The untold story of Moderna — Building a new future for medicine — Startups poised to take off
Welcome to Dispensed. Inside, why teams of healthcare workers spend their days flipping seriously i…
Lydia Ramsey
2 stocks to buy on the Amazon Pharmacy news
These are Business Insider's biggest healthcare stories for November 19.
Lydia Ramsey Pflanzer
Don't hold your breath for a coronavirus vaccine. Here are the 7 biggest challenges we still need to overcome.
Creating a coronavirus vaccine is just half the battle. To stop the pandemic, we then need to mass-…
Andrew Dunn,Aylin Woodward
FDA director: The agency expects to approve Pfizer's vaccine after today's crucial hearing
FDA advisors are deciding whether to recommend approving the Pfizer vaccine. FDA's Stephen Hahn exp…